BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Cellectricon Release: Presenting Phenotypic Screening Strategies for Chronic Pain Research


8/20/2013 8:53:38 AM

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Molndal, Sweden – 20 August 2013 – Cellectricon, a leading provider of advanced cell-based screening technologies and services, invites researchers to join the webinar entitled “Phenotypic Screening Strategies for Chronic Pain Research”, taking place on 5 September, 11:00 am to 12:00pm EDT. Investigating the latest approaches to phenotypic assay designs for drug discovery in chronic pain research, the webinar will explain how researchers can enhance neurobiology workflows using Cellectricon’s comprehensive phenotypic screening platform and highly relevant disease models.

Dr Paul Karila (Head of Discovery Services, Cellectricon), and Dr Charlotta Blom (Senior Researcher, Cellectricon) will talk the viewers through the many benefits of using phenotypic assays for drug discovery in the treatment of chronic pain. Viewers will learn how to increase the chance of identifying modulators of a disease, even without information on the target. Furthermore, by focusing on downstream functional responses such as neuronal excitability, identifying novel mechanisms as well as compounds acting on the pain pathway is now possible.

The webinar presents an ideal opportunity for researchers and lab managers to keep up to date with the most recent innovations in areas including neurobiology, translational science, drug discovery and electrophysiology. To discuss these technologies in more depth, Cellectricon will also be attending the 7th Annual Pain & Migraine Therapeutics Summit, 25-26 September in Boston (USA).

Register for the webinar here, or for more information on Cellectricon visit www.cellectricon.com

About Cellectricon

Cellectricon provides state-of-the-art discovery services and enabling technologies to accelerate drug discovery and cell-based research. Our compound profiling services in excitable cells and native tissue provide researchers with decision-making insight into the science of cytoskeletal disturbances, particularly focusing on chronic pain.

Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES